T. Tyler Luyben

T. Tyler Luyben is a Principal at Sixty Degree Capital since January 2021, focusing on investment strategies in the venture industry and providing scientific expertise to the investment team. Previously, T. Tyler Luyben served as a Drug Development Associate at Edesa Biotech from March 2018 to July 2020, overseeing clinical development projects, regulatory filings, and business development initiatives. T. Tyler Luyben's academic background includes a Doctor of Philosophy in Molecular Genetics from the University of Toronto and a Bachelor of Science in Genetics from Western University. Additional research experience includes a postdoctoral position at Lunenfeld-Tanenbaum Research Institute, where T. Tyler Luyben worked on memory formation using advanced imaging technology, and doctoral studies at The Samuel Lunenfeld Research Institute. Early research roles involved internships focused on hyperlipidemia at Robarts Research Institute.